Skip to main content
. 2003 Jul 29;89(3):585–592. doi: 10.1038/sj.bjc.6601131

Figure 6.

Figure 6

Impact of drugs and drug combination on caspase 3 activity. ZD1839 alone had no effect on caspase 3 activity, but the combination of ZD1839 with cisplatin–5FU led to a supra-additive increase in caspase 3 activity at 96 h. *P<0.05 vs CFPU combination, bars indicate standard deviation from the mean of three separate experiments.